Clicky

Omega Therapeutics, Inc.(OMGA) News

Date Title
Oct 15 Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
Aug 6 Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates
Aug 6 Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
Aug 6 Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
Jun 24 Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
May 8 Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 7 Omega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
May 6 Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
May 6 Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Apr 25 Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 23 Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
Apr 17 Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Apr 9 Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
Apr 3 Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know
Mar 29 We Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully
Mar 28 Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates
Mar 28 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
Mar 6 Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
Jan 10 The 3 Best Biotech Stocks to Buy in January 2024
Dec 4 Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference